Industry

Strategic Collaboration Delivers Near 100% Fulfillment Rates, 100% Real-Time Visibility, and Resilient Medical Logistics Across 14 Hospitals MIAMI–(BUSINESS WIRE)–#Collaboration—Ryder System, Inc. (NYSE: R) and BJC Health System, based in St. Louis, Missouri, secure the prestigious SMI Tom Hughes Collaboration Award for their transformative work in reshaping the healthcare supply chain to improve patient care and … [Read more…]

LONDON & MILAN–(BUSINESS WIRE)–#AI–Biocentis, a life-science company at the forefront of genetic innovation, has raised $19 million to advance its mission of protecting health, agriculture, and biodiversity from the growing global threats posed by insects. The financing includes a $13M seed equity investment led by the Grantham Foundation for the Protection of the Environment (US) … [Read more…]

SHANGHAI–(BUSINESS WIRE)–YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for YOLT-203, an in vivo gene-editing therapy for the treatment of Primary Hyperoxaluria Type 1 (PH1). The global multicenter, randomized, double-blind, placebo-controlled … [Read more…]

Decision underlines a commitment to leveraging advanced safety technology by QGAir as part of a holistic safety program. Brazos Safety Systems is proud to support QGAir in this program. BRISBANE, AUSTRALIA–(BUSINESS WIRE)–#AviationSafety–Queensland Government Air (“QGAir”), the State’s dedicated aviation capability, continues to provide world-leading emergency response and support services to communities across Queensland. Operating as … [Read more…]

FREMONT, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at the Lotte New York Palace in New York, NY. About Personalis, Inc. At Personalis, we are transforming the active … [Read more…]

The patent, issued to Brainiac’s parent company Ingenuity Brands, spans fruit and vegetable products fortified with omega-3s and choline through February 2040 SAN FRANCISCO–(BUSINESS WIRE)–Brainiac Foods and its parent company, Ingenuity Brands, today announced that the United States Patent and Trademark Office (USPTO) has issued a patent covering food products nutritionally enhanced with omega-3s and … [Read more…]

Data underscores a deepening culture crisis in healthcare and an opportunity for organizations to rebuild trust, engagement, and balance MIDVALE, Utah–(BUSINESS WIRE)–Only 18% of physicians report being highly engaged in their workplaces, according to new data from CHG Healthcare’s Physician Sentiment Survey. The findings reveal a deepening culture crisis driven by administrative burdens, staffing shortages, … [Read more…]

Peer-reviewed data published in Neurosurgery show that SOLOPASS® 2.0 delivers significantly higher accuracy than free-hand EVD placement. SOLOPASS® 2.0 achieved consistent accuracy across all clinician experience levels. BLUE BELL, Pa.–(BUSINESS WIRE)–inTRAvent Medical Partners LP, a pioneer in bedside, image-guided neurosurgical innovation, today announced the publication of a peer-reviewed study in Neurosurgery evaluating the accuracy of … [Read more…]

Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the European Commission (EC) for all previously approved indications for Remsima™ IV powder formulation1 The approval is based on the comparability data between infliximab powder formulation and the liquid formulation2 The new liquid formulation of infliximab, available in … [Read more…]

MVM Partners joins as Avanzanite’s first institutional investor. Funding will scale Avanzanite’s existing infrastructure in all 32 countries in Europe, propel current launches, and support further product alliances and acquisitions. In just 3 years, Avanzanite has entered 3 strategic alliances and actively launched 3 rare disease medicines. Avanzanite’s Q3 2025 revenue tripled year-on-year and climbed … [Read more…]